Tricuspid Valve Regurgitation

0
Pipeline Programs
1
Companies
2
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

TRiCares
TRiCaresGermany - Aschheim
2 programs
Transcatheter Tricuspid Valve ReplacementN/A1 trial
Transcatheter Tricuspid Valve ReplacementN/A1 trial
Active Trials
NCT06581471RecruitingEst. Dec 2030
NCT06506942RecruitingEst. Mar 2031

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
2028
2029
2030
2031
TRiCaresTranscatheter Tricuspid Valve Replacement
TRiCaresTranscatheter Tricuspid Valve Replacement

Clinical Trials (2)

NCT06506942TRiCaresTranscatheter Tricuspid Valve Replacement

The TRICURE EFS Study

Start: Sep 2024Est. completion: Mar 2031
N/ARecruiting
NCT06581471TRiCaresTranscatheter Tricuspid Valve Replacement

The TRICURE EU Pivotal Study

Start: Aug 2024Est. completion: Dec 2030
N/ARecruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials
1 companies competing in this space